Skip to content
Ichilov Medical Center
Oncology

Treatment of T-Cell Precursor Lymphoma in Israel

The Israeli Ichilov Clinic is equipped with the latest generations of diagnostic and therapeutic equipment. Here, precise diagnostics are conducted, and the most innovative methods for treating T-cell precursor lymphoma in Israel are utilized. The medical center employs oncologists and hematologists recognized by the global medical community with successful experience in combating complex and rare types of hematological oncopathologies.

100%
online consultations with an Israeli expert are organized within 2-3 days
>30%
of patients received innovative treatments unavailable in local clinics
2384
patients have utilized comprehensive medical services

Treatment of T-Cell Precursor Lymphoma in IsraelDiagnostics and treatment are conducted by a multidisciplinary team of doctors, allowing for comprehensive management of the therapy process. Here, combinations of standard protocols with innovative approaches and rehabilitation procedures are applied. Patients gain access to the latest drugs and therapeutic techniques.

Ichilov has many years of experience in organizing treatment for international patients, including assistance with organizational and logistical issues, translation of medical documentation, personal support, and accommodation for patients' families.

About the Disease

T-cell precursor lymphoma refers to tumours that develop from undifferentiated T-lymphocyte cells. Malignant transformation of T-lymphoblasts occurs, which are unable to mature into mature T-cells. Instead, they begin to divide uncontrollably and accumulate in the bone marrow, as well as spread through the bloodstream to other organs and tissues, manifesting symptoms of leukemia. In the international classification, the pathology is classified as acute lymphoblastic leukemia/lymphoma (ALL/LBL) with a designation of T-cell phenotype.

Scientists cannot pinpoint the exact causes of the disruption in the development of T-cell precursors. However, there is a possibility that exposure to certain chemicals, radiation, and genetic anomalies may increase the risks of occurrence. Possible provoking factors may also include immunodeficiency states, previous chemotherapy or radiotherapy, and viral infections such as HIV or HTLV-1.

The most characteristic signs of T-cell precursor lymphoma may include:

  • chronic fatigue, loss of appetite, unintended weight loss;
  • anemia;
  • leukopenia and increased susceptibility to infections;
  • thrombocytopenia with an increased tendency to bleeding and bruising;
  • enlargement of lymph nodes, spleen, or liver;
  • sharp bone pain;
  • fever, night sweats, and chills (B-symptoms).

Treatment Methods for the Disease

Treatment of T-cell precursor lymphoma at Ichilov Clinic is based on current international protocols and is adapted to the specific characteristics of the disease's progression and the needs of the individual patient. The goal of therapy is to achieve and maintain remission, prevent relapses, minimize side effects, and improve prognosis.

Comprehensive Systemic 4-Stage Chemotherapy

The treatment program typically consists of 3-4 sequential chemotherapy cycles.

  1. Induction. The initial, most intensive phase, aimed at achieving complete remission – the absence of malignant cells in the clinical picture and bone marrow morphology. To achieve the effect in this phase, high doses of chemotherapy drugs are used.
  2. Consolidation. After achieving remission, therapy focuses on destroying remaining cancer cells that could potentially provoke a relapse. Consolidation chemotherapy helps to solidify the results of the induction phase.
  3. Maintenance. Relatively lighter chemotherapy regimens to maintain remission and prevent setbacks.
  4. Supportive. In this phase, drugs are used to prevent and treat infectious complications, blood transfusions, and blood substitutes, as well as medications to maintain homeostasis.

Hematopoietic Stem Cell Transplantation

In cases of high relapse risk or after a relapse has occurred, allogeneic stem cell transplantation may be considered as one of the methods of comprehensive treatment.

To restore the bone marrow and immune system after intensive chemotherapy or radiotherapy, healthy donor stem cells are transplanted to the patient. The ability to recognize and destroy the recipient's malignant cells serves as an additional mechanism in combating the disease.

In some cases, autologous transplantation is used – when the transplant material consists of the patient's own stem cells.

Radiotherapy

This method of irradiation is used for local effects, especially for tumours in the mediastinal area or to prevent the nervous system from being infiltrated by leukemic cells. The Ichilov Clinic is equipped with modern TrueBeam and Lunac linear accelerators. This state-of-the-art equipment allows for more precise targeting of radiation on the tumour, minimizing damage to surrounding healthy tissues, reducing the risks of side effects, and increasing treatment effectiveness.

Targeted and Immune Therapies

A large complex of innovative approaches aimed at activating the body's own reserves and "highlighting" specific molecular targets. The use of monoclonal antibodies, tyrosine kinase inhibitors, and other drugs is based on identifying specific markers or processes in T-cells. For instance, CAR-T therapy allows for the recognition and destruction of malignantly altered lymphoblasts using a chimeric antigen receptor (CAR), yielding the most significant results.

  • Bone marrow transplantation in Israel
  • Radiotherapy
  • Chemotherapy
  • CAR-T therapy

Diagnostic Methods for the Disease

Diagnosing T-cell precursor lymphoma requires a comprehensive approach. The Ichilov Clinic has developed a protocol for diagnosing the pathogenetic process of T-lymphoblast malignancy, allowing for quick and accurate diagnosis. The procedure consists of several stages and typically takes three days.

First Day

During the first appointment, the doctor becomes acquainted with the complaints and identifies characteristic symptoms, collects the medical history. A physical examination is conducted, during which the lymph nodes are palpated for size changes, and signs of liver and spleen enlargement are sought.

Second Day

  • Blood tests
  • Biopsy and histological examination
  • Immunophenotyping and classification of lymphoblasts
  • Cytogenetic and molecular genetic studies
  • Imaging methods: CT or PET-CT

Third Day

A comprehensive approach to diagnostics includes close interaction among various specialists: hematologists, oncologists, radiologists, histopathologists, and doctors from other related fields. Collaborative work allows for consideration of all nuances of the disease's progression in the specific patient and determining the most effective treatment plan.

  • Computed tomography
  • Diagnostics – PET CT
  • Biopsy and histological studies

How Much Does Treatment Cost

Each treatment plan at the Ichilov Medical Center is created considering the individual characteristics of the patient, including disease manifestations and current health. Prices are formed based on the volume and complexity of diagnostic studies, therapeutic methods, and the need to involve specialized medical professionals.

You can always get answers to your questions by calling or writing in the online chat on the website or filling out the feedback form. A qualified healthcare coordinator will explain in detail what influences the cost of treatment, what is included in the medical program, and what the average costs of specific services are. Find out complete and up-to-date information about the equipment the medical center is equipped with, the capabilities of the departments, the qualifications and experience of specialists, their ratings, and patient reviews.

Advantages of Lymphoma Treatment in Israel

  1. Advanced medical technologies
  2. Highly qualified specialists working collaboratively
  3. Individual approach
  4. Integrative medicine, the latest methods and drugs that have undergone clinical trials
  5. Experience in coordinating international patients

Israel is known worldwide for its impressive results in treating oncological hematological conditions of the lymphatic system. Today, you have the opportunity to receive a consultation from a recognized expert in this field. Through video communication via Zoom or Skype, the doctor can conduct an initial diagnosis based on the tests you have, discuss modern approaches to treating lymphoblastic lymphomas, and recommend subsequent steps.

Get a treatment plan

Attach your discharge notes and imaging — Ichilov physicians will review and propose an optimal plan.

    Request a callback

    A coordinator will call back shortly and answer your questions.